Hereditary Kidney Disorders
Some kidney diseases result from genetic factors. Polycystic Kidney Disease (PKD), for example, is a genetic disorder in which many cysts grow in the kidneys. PKD cysts can slowly switch much. Some kidney complications may show up even before birth. Examples contain autosomal receding PKD, a rare form of PKD, and other developing problems that interfere with the normal formation of the nephrons. The signs of kidney disease in children vary. A child may grow remarkably slowly, may vomit frequently, or may have back or side pain.
- Alport Syndrome
- Bartter Syndrome
- Cystic Diseases of the Kidney
- Horseshoe Kidney
- Medullary Sponge Kidney
- Megaureter and Other Congenital Ureteral Anomalies
Related Conference of Hereditary Kidney Disorders
April 16-17, 2025
13th European Congress on Nephrology, Internal Medicine and Kidney Diseases
Paris, France
May 05-06, 2025
7th International Conference on Clinical Immunology, Neuropharmacology and Drug Development
Rome, Italy
Hereditary Kidney Disorders Conference Speakers
Recommended Sessions
- Cardiovascular Impacts of Kidney Diseases
- Clinical Nephrology
- Nephrology and Hypertension
- Nephrology Nursing & Health Care
- Dialysis
- Glomerular Diseases
- Hereditary Kidney Disorders
- Hypertension & Diabetic Associated Kidney Diseases
- Kidney and Bladder Stones
- Kidney Diseases
- Kidney Transplantation
- Kidney Urology
- Nephrological Treatment
- Nephrology
- Pediatric Nephrology
- Pediatric Urology
- Renal Nutrition
- Renal Pathology-Immunology
- Tubular and Interstitial Diseases
- Urinary Tract Infections
- Urologic Diseases
- Urology
Related Journals
Are you interested in
- Acute Kidney Injury - Kidney Care 2026 (UK)
- Advanced Imaging Techniques in Neuropharmacology - Neuropharmacology 2025 (Italy)
- Advances in Immuno-Oncology for CNS Tumors - Neuropharmacology 2025 (Italy)
- Advances in Kidney Transplantation - Nephrologists 2025 (France)
- AI-Driven Drug Discovery in Neuropharmacology - Neuropharmacology 2025 (Italy)
- Artificial Intelligence and Machine Learning in Renal Diagnostics - EURO NEPHROLOGY 2025 (Italy)
- Autoimmunity and Neuropharmacology: New Insights - Neuropharmacology 2025 (Italy)
- Biomarkers in Neuroimmune and Neuroinfectious Diseases - Neuropharmacology 2025 (Italy)
- Biomarkers of Kidney Diseases - Euro Nephrology Summit 2025 (France)
- Blood-Brain Barrier: Challenges and Solutions - Neuropharmacology 2025 (Italy)
- Cardiorenal Syndrome - Euro Nephrology Summit 2025 (France)
- Cell-Based Therapies in Neuroimmune Disorders - Neuropharmacology 2025 (Italy)
- Challenges in Paediatric Nephrology - Nephrologists 2025 (France)
- Chronic Kidney Disease and Diabetes - Nephrologists 2025 (France)
- Clinical Nephrology - Euro Nephrology Summit 2025 (France)
- Clinical Nephrology - Kidney Care 2026 (UK)
- Clinical Trails in Kidney Therapy - Nephrologists 2025 (France)
- Clinical Trials in Neuroimmunology - Neuropharmacology 2025 (Italy)
- CRISPR Innovations for Kidney Disorders - EURO NEPHROLOGY 2025 (Italy)
- Diabetic Nephropathy - Euro Nephrology Summit 2025 (France)
- Diabetic Nephropathy - Kidney Care 2026 (UK)
- Diagnostic, Imaging and Radiation Techniques - Euro Nephrology Summit 2025 (France)
- Diet for Kidney Health - Euro Nephrology Summit 2025 (France)
- Digital Health Innovations and Biomarker Development - EURO NEPHROLOGY 2025 (Italy)
- Drugs for Kidney Diseases - Kidney Care 2026 (UK)
- Drugs used in the treatment of Kidney Diseases - Euro Nephrology Summit 2025 (France)
- Emerging Biomarkers in Nephrology - Nephrologists 2025 (France)
- Emerging Neuroprotective Agents - Neuropharmacology 2025 (Italy)
- Emerging Therapies for Polycystic Kidney Disease - EURO NEPHROLOGY 2025 (Italy)
- Environmental Risk Factors and Kidney Disease - EURO NEPHROLOGY 2025 (Italy)
- Epigenetic Modulation in Neuroimmune Disorders - Neuropharmacology 2025 (Italy)
- Ethical and Regulatory Considerations in Neuropharmacology - Neuropharmacology 2025 (Italy)
- Ethics and Policy in Renal Medicine - EURO NEPHROLOGY 2025 (Italy)
- Ethics in Kidney Donation and Transplantation - Nephrologists 2025 (France)
- Ethics in Kidney Transplantation - EURO NEPHROLOGY 2025 (Italy)
- Fluid and Electrolyte Disorders in Nephrology - EURO NEPHROLOGY 2025 (Italy)
- Gene Therapy and CRISPR in Neuroimmunology - Neuropharmacology 2025 (Italy)
- Genetics of Kidney Disease - Nephrologists 2025 (France)
- Geriatric Nephrology - Kidney Care 2026 (UK)
- Geriatric Nephrology and Aging Populations - EURO NEPHROLOGY 2025 (Italy)
- Global Perspectives on kidney Health - Nephrologists 2025 (France)
- Glomerular Disease - Euro Nephrology Summit 2025 (France)
- Hereditary Kidney Disorders - Euro Nephrology Summit 2025 (France)
- Hypertension associated with Kidney Diseases - Euro Nephrology Summit 2025 (France)
- Immunomodulation and Targeted Therapies for Glomerular Diseases - EURO NEPHROLOGY 2025 (Italy)
- Immunomodulation in Stroke and Traumatic Brain Injury - Neuropharmacology 2025 (Italy)
- Innovations in Dialysis Techniques - Nephrologists 2025 (France)
- Innovations in Home-Based Renal Therapy: Smart Dialysis Devices - EURO NEPHROLOGY 2025 (Italy)
- Innovative Approaches to Stone Disease - Nephrologists 2025 (France)
- Integrating care for Kidney Failure - Nephrologists 2025 (France)
- Kidney and Bladder Cancer - Kidney Care 2026 (UK)
- Kidney Disease in Aging Population - Nephrologists 2025 (France)
- Kidney Diseases & Diagnosis of Kidney Diseases - Kidney Care 2026 (UK)
- Kidney Health and Nutrition - Nephrologists 2025 (France)
- Kidney Stones - Euro Nephrology Summit 2025 (France)
- Kidney Transplantation - Euro Nephrology Summit 2025 (France)
- Kidney Transplantation - Kidney Care 2026 (UK)
- Kidney-on-a-Chip Technology - EURO NEPHROLOGY 2025 (Italy)
- Managing Chronic Kidney Disease - Nephrologists 2025 (France)
- Microbiome-Targeted Therapies in Neurology - Neuropharmacology 2025 (Italy)
- Minimally Invasive Urological surgery - Nephrologists 2025 (France)
- Molecular Mechanisms of Neuroimmune Responses - Neuropharmacology 2025 (Italy)
- Nanomedicine in Renal Therapeutics - EURO NEPHROLOGY 2025 (Italy)
- Nanotechnology in Neuropharmacology - Neuropharmacology 2025 (Italy)
- Nephrology - Euro Nephrology Summit 2025 (France)
- Nephrology - Kidney Care 2026 (UK)
- Nephrology Nursing - Kidney Care 2026 (UK)
- Nephrotic Syndrome - Euro Nephrology Summit 2025 (France)
- Neuroimmune Crosstalk in Metabolic Disorders - Neuropharmacology 2025 (Italy)
- Neuroimmune Interactions in Psychiatric Disorders - Neuropharmacology 2025 (Italy)
- Neuroimmune Pathways in Pain Management - Neuropharmacology 2025 (Italy)
- Neuroinflammation: Mechanisms and Therapeutic Strategies - Neuropharmacology 2025 (Italy)
- Neuropharmacological Interventions in Neurodegenerative Disorders - Neuropharmacology 2025 (Italy)
- Neurotoxicology and Immunotoxicology - Neuropharmacology 2025 (Italy)
- Next-Generation Immunotherapies in Neurological Disorders - Neuropharmacology 2025 (Italy)
- Novel Drug Delivery Systems for Neuroimmune Agents - Neuropharmacology 2025 (Italy)
- Nutritional Genomics and Personalized Renal Dietetics - EURO NEPHROLOGY 2025 (Italy)
- Patient-Centric Kidney Care - Nephrologists 2025 (France)
- Pediatric Nephrology - Euro Nephrology Summit 2025 (France)
- Pediatric Nephrology - Kidney Care 2026 (UK)
- Pediatric Nephrology and Developmental Disorders - EURO NEPHROLOGY 2025 (Italy)
- Pediatric Neuroimmunology: Challenges and Innovations - Neuropharmacology 2025 (Italy)
- Personalized Medicine in Neuroimmunology - Neuropharmacology 2025 (Italy)
- Pharmacogenomics and Personalized Medicine in Renal Therapeutics - EURO NEPHROLOGY 2025 (Italy)
- Pharmacogenomics in Renal Drug Response - EURO NEPHROLOGY 2025 (Italy)
- Precision Neuropharmacology: From Bench to Bedside - Neuropharmacology 2025 (Italy)
- Preventing Acute Kidney Injury - Nephrologists 2025 (France)
- Psychosocial aspects of Kidney Disease - Nephrologists 2025 (France)
- Regenerative Medicine and Tissue Engineering in Nephrology - EURO NEPHROLOGY 2025 (Italy)
- Regenerative Medicine in Neuropharmacology - Neuropharmacology 2025 (Italy)
- Renal Nutrition and Metabolism - Kidney Care 2026 (UK)
- Renal Pathology & Immunology - Kidney Care 2026 (UK)
- Robotic Surgery - Kidney Care 2026 (UK)
- Role of Pharmacotherapy in Nephrology - Nephrologists 2025 (France)
- Sophisticated Imaging: 3D Mapping and Evaluation - EURO NEPHROLOGY 2025 (Italy)
- Stages of Kidney Diseases - Euro Nephrology Summit 2025 (France)
- Stem Cell and Tissue Engineering in Nephrology - EURO NEPHROLOGY 2025 (Italy)
- Stem cells in Renal Disorders - Euro Nephrology Summit 2025 (France)
- Technological Advancements in Nephrology - Euro Nephrology Summit 2025 (France)
- Telehealth in Urology - Nephrologists 2025 (France)
- The End Stage Renal Diseases & Chronic Kidney Diseases - Kidney Care 2026 (UK)
- The Neuroimmune Interface in Autoimmune Diseases - Neuropharmacology 2025 (Italy)
- The Role of AI in Nephrology - Nephrologists 2025 (France)
- Understanding Glomerular Diseases - Nephrologists 2025 (France)
- Urological Emergencies: Quick Response - Nephrologists 2025 (France)
- Urological Oncology: Current Trends - Nephrologists 2025 (France)
- Urology / Urinary Tract Infections - Kidney Care 2026 (UK)
- Urology and Sexual Health - Nephrologists 2025 (France)
- Viral Infections and Neuroimmune Responses - Neuropharmacology 2025 (Italy)